Columbia Team targets Bladder and Esophageal Cancers
- catherinespina
- Nov 12
- 1 min read

Columbia scientists are leading a multi-institutional effort to investigate how bladder and esophageal cancer cells shift identity to resist treatment. Their research could pave the way for new therapies that reverse this resistance and improve outcomes.
Originally published by Columbia University Irving Medical Center. Read the full article here.
Original Publish Date: May 2, 2025



Comments